HUP0102728A2 - Methods and transdermal compositions for pain relief - Google Patents

Methods and transdermal compositions for pain relief

Info

Publication number
HUP0102728A2
HUP0102728A2 HU0102728A HUP0102728A HUP0102728A2 HU P0102728 A2 HUP0102728 A2 HU P0102728A2 HU 0102728 A HU0102728 A HU 0102728A HU P0102728 A HUP0102728 A HU P0102728A HU P0102728 A2 HUP0102728 A2 HU P0102728A2
Authority
HU
Hungary
Prior art keywords
methods
pain relief
transdermal compositions
pain
patients
Prior art date
Application number
HU0102728A
Other languages
Hungarian (hu)
Inventor
Robert W. Murdock
C. Donald Williams
Original Assignee
Pharmaceuticals Applications Associates, LLC.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applications Associates, LLC. filed Critical Pharmaceuticals Applications Associates, LLC.
Publication of HUP0102728A2 publication Critical patent/HUP0102728A2/en
Publication of HUP0102728A3 publication Critical patent/HUP0102728A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya egy transzdermális készítmény a betegek fájdalmánakkezelésére, azzal jellemezve, hogy (a) egy kétfázisú oldékonyságú aminbetegek fájdalmának kezelésére hatásos mennyiségét; és (b) az amintranszdermális bevitelére alkalmas, gyógyszerészetileg elfogadhatóvivőanyagot tartalmaz. ÓThe subject of the invention is a transdermal preparation for the treatment of pain in patients, characterized by (a) an effective amount of a biphasic soluble amine for the treatment of pain in patients; and (b) contains a pharmaceutically acceptable carrier suitable for transdermal administration of the amine. HE

HU0102728A 1998-06-29 1999-06-29 Methods and transdermal compositions for pain relief HUP0102728A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05
PCT/US1999/014653 WO2000000120A1 (en) 1998-06-29 1999-06-29 Methods and transdermal compositions for pain relief

Publications (2)

Publication Number Publication Date
HUP0102728A2 true HUP0102728A2 (en) 2002-03-28
HUP0102728A3 HUP0102728A3 (en) 2002-12-28

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102728A HUP0102728A3 (en) 1998-06-29 1999-06-29 Methods and transdermal compositions for pain relief

Country Status (18)

Country Link
EP (1) EP1093348A4 (en)
JP (1) JP2002519310A (en)
KR (1) KR20010078754A (en)
CN (1) CN1331576A (en)
AU (1) AU4841599A (en)
BG (1) BG105175A (en)
BR (1) BR9912508A (en)
CA (1) CA2335837A1 (en)
HR (1) HRP20000905A2 (en)
HU (1) HUP0102728A3 (en)
ID (1) ID28213A (en)
IL (1) IL140420A0 (en)
MX (1) MXPA00012767A (en)
NO (1) NO20006604L (en)
PL (1) PL345216A1 (en)
SK (1) SK20012000A3 (en)
TR (1) TR200003801T2 (en)
WO (1) WO2000000120A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
ATE289295T1 (en) 1997-04-22 2005-03-15 Euro Celtique Sa THE USE OF SEMICARBAZONES AND THIOSEMICARBAZONES SUBSTITUTED BY CARBOCYCLIC AND HETEROCYCLIC MATERIALS AS SODIUM CHANNEL BLOCKERS
EP1629843A3 (en) * 1999-07-01 2006-03-15 Pharmacia & Upjohn Company LLC Reboxetine for treating chronic fatigue syndrome
ATE305307T1 (en) 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc REBOXETINE FOR THE TREATMENT OF MIGRAINE HEADACHE
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
IN191512B (en) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE10042412B4 (en) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN101797221B (en) 2002-12-13 2013-06-12 杜雷科特公司 Oral drug delivery system comprising high viscosity liquid carrier materials
JP2005154368A (en) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd Analgesic agent for neuropathic pain containing disopyramide
JP4807721B2 (en) * 2004-01-29 2011-11-02 株式会社 メドレックス Anti-inflammatory analgesic topical
SI2767292T1 (en) 2004-09-17 2017-01-31 Durect Corporation Sustained Local Anesthetic Composition Containing SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (en) * 2006-05-17 2007-11-29 Kenji Yoshida Skin care preparation
KR100880748B1 (en) * 2006-08-29 2009-02-02 정헌택 Pharmaceutical composition containing demethoxycurcumin to prevent restenosis
ES2388355T3 (en) 2006-11-03 2012-10-11 Durect Corporation Transdemic delivery systems comprising bupivacaine
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5826742B2 (en) * 2009-05-07 2015-12-02 ドンコック ファーマシューティカル カンパニー リミテッド Pharmaceutical composition for preventing or treating nerve damage and disease
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
WO2015123272A1 (en) * 2014-02-11 2015-08-20 Dr. Reddy's Laboratories Ltd. Parenteral compositions of celecoxib
BR112021007877A2 (en) 2018-10-26 2021-08-03 Viramal Limited mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN115666621A (en) 2020-01-13 2023-01-31 度勒科特公司 Sustained release drug delivery systems with reduced impurities and related methods
FR3108841B1 (en) * 2020-04-06 2023-11-03 Algotherapeutix TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
WO2000000120A9 (en) 2000-03-30
BR9912508A (en) 2001-05-02
WO2000000120A1 (en) 2000-01-06
CN1331576A (en) 2002-01-16
EP1093348A1 (en) 2001-04-25
BG105175A (en) 2001-11-30
CA2335837A1 (en) 2000-01-06
HUP0102728A3 (en) 2002-12-28
KR20010078754A (en) 2001-08-21
AU4841599A (en) 2000-01-17
IL140420A0 (en) 2002-02-10
HRP20000905A2 (en) 2001-08-31
JP2002519310A (en) 2002-07-02
EP1093348A4 (en) 2003-07-16
TR200003801T2 (en) 2001-06-21
ID28213A (en) 2001-05-10
NO20006604L (en) 2001-02-28
MXPA00012767A (en) 2002-08-09
NO20006604D0 (en) 2000-12-22
PL345216A1 (en) 2001-12-03
SK20012000A3 (en) 2001-08-06

Similar Documents

Publication Publication Date Title
HUP0102728A2 (en) Methods and transdermal compositions for pain relief
HUP0101543A2 (en) Pharmaceutical compositions for treating femal sexual dysfunction
NO993520D0 (en) Dosage forms and methods for improving erectile dysfunction
ATE246919T1 (en) IMPROVED TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TREATMENT OF PARKINSON'S DISEASE
HUP0203870A2 (en) Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
HUP0202570A1 (en) Compositions and therapeutic methods involving isoflavones and analogues thereof
HUP0103078A2 (en) Pharmaceutical compositions and methods for treating cataracts
HUP0203590A2 (en) Remedies for diseases in association with decrease in bone mass
DK1256339T3 (en) Transdermal therapeutic system for obtaining high plasma levels of rotigotine in the treatment of Parkinson's disease
HUP0301349A2 (en) Formulations for il-11
NO20004419D0 (en) New use
DE50114474D1 (en) COMBINATION OF A TRANSDERMAL THERAPEUTIC SYSTEM AND ORAL AND / OR PARENTERAL PREPARATION CONTAINING DOPAMINAGONISTS FOR THE TREATMENT OF DOPAMINERGER ILLNESSES
UA32457C2 (en) Drug (variants) and methods for exposure to drug
HUP0203682A2 (en) Method for administering a phosphodiesterase 4 inhibitor
HUP0000873A2 (en) The use of levobupivacaine in facial surgery
BR0007452A (en) Use of melagatran or a pharmaceutically acceptable derivative or prodrug thereof, method of treating inflammation, and, pharmaceutical formulation for use in treating inflammation
SE9902597D0 (en) New use
HUP0203050A2 (en) Treating endometriosis or infertility, or improving fertility
HUP0402326A2 (en) Pharmaceutical composition for prevention of addiction in pain management
HUP0402062A2 (en) Use of alkanoyl l-carnitine for the treatment of erectile dysfunction and pharmaceutical compositions containing them
ATE331523T1 (en) STATIN THERAPY TO IMPROVE MAINTAINING COGNITIVE FUNCTION
HUP9904578A2 (en) Use of xanomeline for the preparation of pharmaceutical compositions treating bipolar disorder
HUP0300313A2 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain
DE60130253D1 (en) COMPOSITIONS FOR PREVENTING ADHESION
HUP0300043A2 (en) Method and composition for the treatment of pain